Single-Dose Treatment of Covid-19 with Pegylated Interferon Lambda

The February 9th issue of The New England Journal of Medicine includes an article on a randomized controlled trial of a new antiviral treatment for Covid-19.1 Interferon lambda (IL-28 and -29) is an antiviral protein that has a protective effect at epithelial surfaces.2 It has been studied for antiviral activity against SARS-CoV-2 and in two […]